FDA daily for Saturday, August 1, 2026
11 FDA records across 3 sections.
Drug shortagesCovers FDA's Fri, Jul 31 (yesterday)1
- Triamcinolone Acetonide Injection
Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) — Harrow Eye, LLC
Drug approvalsCovers FDA's Sat, Jul 25 (a week ago)1
- DYNA-HEX 2
CHLORHEXIDINE GLUCONATE — XTTRIUM
Label changesCovers FDA's Sat, Jul 18 (two weeks ago)9
- Drug label
- ADVANCED WART REMOVER
Guangzhou ChuanMa International Trading Co.,Ltd.
- Tea Tree Antifungal
HONG KONG UNORDERED TRADING CO., LIMITED
- ACTIV-CHARCOAL ANTIFUNGAL
HONG KONG UNORDERED TRADING CO., LIMITED
- SOVS MULTI-PURPOSE NAIL REPAIR
Wenzhou Yuyuan Pharmaceutical Co., Ltd.
- equate allergy relief
Walmart Inc.
- Levofloxacin
HAWAII REPACK, INC.
- Hydrocodone Bitartrate and Acetaminophen
Eywa Pharma Inc
- Clindamycin hydrochloride
HAWAII REPACK, INC.
How the FDA Daily Is WrittenSources, dates and what gets flagged
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.
Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.
Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.